Inform Diagnostics and Quisitive Expand Relationship to Develop Subspecialty Anatomic Pathology Real-Time Biopsy Tracking Solution
TORONTO and IRVING, Texas – TheNewswire - July 9, 2020 — Quisitive Technology Solutions (TSXV:QUIS) (OTC:QUISF) and Inform Diagnostics, a leading U.S. commercial subspecialty anatomic pathology provider, today announced an agreement to expand their relationship to develop a real-time, biopsy tracking solution. This new collaboration will result in a mobile application powered by Microsoft Azure, Azure Artificial Intelligence (AI) and Microsoft Teams technologies. This purpose-built solution will provide clinicians with real-time information at their point of need.
This expanded relationship to build a transformative solution for better patient care builds on Quisitive’s and Inform Diagnostics’ accelerated project over the past 18 months to fully modernize Inform Diagnostics’ IT infrastructure. This transformation has enabled Inform Diagnostics to innovate and scale to provide unparalleled quality, service and solutions to clinicians and their patients. The new IT infrastructure replacing legacy systems will be fully deployed across Inform Diagnostics’ labs by year end, including the Phoenix lab providing COVID-19 molecular testing.
“Through this transformative work, Inform Diagnostics addressed our accrued ‘technical debt,’” said Nancy Gay, President and COO at Inform Diagnostics, “By redesigning and rebuilding our data, process and technology substructure to align with our new future-state architecture, we could better support our growth strategy. The work with Quisitive, Microsoft and other providers facilitated easier integration and interoperability of lab and technology changes into our business and technology platforms, with the goal of improving the clinicians’ experience with ease and speed.”
Now in development, the mobile application will provide clinicians with end-to-end, real-time tracking of their patients’ biopsies with 24/7 access to information. This purpose-built solution supports Inform Diagnostics’ commitment to help clinicians capture value and sustainability, with an efficient, innovative solution that saves time and resources.
“Helping Inform Diagnostics transform into a cloud-first company has enabled quick innovation,” said Mike Reinhart, CEO of Quisitive. “Now with its modern cloud infrastructure, Inform Diagnostics can expedite development of this new solution and thankfully not be inhibited by legacy systems. We’re excited to continue our relationship with Inform Diagnostics on an important application that directly impacts the speed of delivering anatomic pathology testing results to enhance patient care.”
Inform Diagnostics is dedicated to providing clinicians and their patients with advanced subspecialty expertise translating to better patient care through precise diagnoses and timely treatment. This new innovative solution underscores Inform Diagnostics’ commitment to delivering the right diagnosis the first time, with accuracy, efficiency and speed, while maintaining the highest quality standards.
“It's incredible to see the innovative solutions that Quisitive and other key partners are applying to address new challenges,” said Patty Obermaier, Vice President, U.S. Health & Life Sciences at Microsoft Corp. “Through their expertise and long-standing commitment to Microsoft technologies, Quisitive is a valuable resource for companies like Inform Diagnostics to help activate capabilities that impact our everyday lives.”
Quisitive will license the mobile application to Inform Diagnostics and use the technology to improve patient care across the healthcare ecosystem.
About Inform Diagnostics
Inform Diagnostics helps clinicians capture value and sustainability by providing their patients with trusted, high‐quality, subspecialty pathology services. With unparalleled quality and experience, Inform Diagnostics provides subspecialty pathologist‐to‐physician interaction with timely, definitive patient diagnoses in gastrointestinal pathology, dermatopathology, hematopathology, neuropathology, breast pathology and genitourinary pathology. Inform Diagnostics is profoundly impacting patient care, one diagnosis at a time, by practicing medicine at the intersection of quality, service and solutions. The company is headquartered in Irving, Texas, with additional state‐of‐the‐art laboratories in Boston, New York City and Phoenix. Visit us at informdiagnostics.com.
Quisitive is a premier Microsoft solutions provider that helps enterprise organizations move, operate, and innovate in the Microsoft cloud: Microsoft Azure, Microsoft Dynamics and Microsoft O365. Quisitive also provides proprietary Software as a Service (“SaaS”) solutions such as CRG emPerform™ and LedgerPay that complement the Microsoft platform. Quisitive serves clients globally with offices in Austin, TX; Dallas, TX; Denver, CO; Minneapolis, MN; Silicon Valley, CA; Washington, DC; Ottawa, ON; and Toronto, ON. For more information, visit http://www.Quisitive.com and follow @BeQuisitive. TSXV: QUIS.